{{Rsnum
|rsid=58425034
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Chromosome=19
|Orientation=plus
|Gene=CYP2B6
|position=41009060
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CYP2B6
}}{{PharmGKB
|RSID=rs58425034
|Name_s=c.646-159G>C
|Gene_s=CYP2A7P1, CYP2B6
|Feature=
|Evidence=PubMed ID:20017669
|Annotation=Risk or phenotype-associated allele: C. Phenotype: This variant is statistically correlated with the mean of maximum transaminase values (ALT) in patients from Mozambique, with higher ALT mean value for C genotype carriers. Study size: 156. Study population/ethnicity: HIV infected patients from Mozambique. Significance metric(s): p= 0.01. Type of association: GN; CO
|Drugs=nevirapine
|Drug Classes=
|Diseases=Drug Toxicity; HIV Infections
|Curation Level=Curated
|PharmGKB Accession ID=PA165111624
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs58425034
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=4
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}